Indofarma Tbk. vs Semen Indonesia (Persero) Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Semen Indonesia (Persero) Tbk. trades at Rp1,695 (market cap 11.68T, 20.89M 24h volume). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 29.9× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | SMGR | |
|---|---|---|
Market Cap | 390.51B | 11.68T |
Volume | — | 20.89M |
Lot | — | 208.88K |
Turnover | — | 35.38B |
Average Price | — | 1,693.71 |
Value | — | 35.38B |
Indicative Equilibrium Price | — | 1,695 |
Indicative Equilibrium Volume | — | 10.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →